Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

bioMerieux' HLA-DR donor detection kit registered:

This article was originally published in Clinica

Executive Summary

bioMerieux's HLA-DR Oligo Detection Kit has been registered by the French health authorities. The microtitre plate, reverse hybridisation assay, for selecting non-related organ and bone marrow transplant donors, combines 24 DNA probes for the detection of over 50 DRB 1,3,4 and 5 specificities. Total test time is 90 minutes. Peel-Freez Clinical Systems (US) has been given exclusive distribution rights for the kit in the US, Canada and Mexico, under a three-year contract. Meanwhile, US clinical trials of the assay are under way.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT094374

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel